MedPath

Comparison of two doses of citrate in regional citrate anticoagulation during hemodialysis

Phase 4
Completed
Conditions
hemodialysis
kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12613001340729
Lead Sponsor
niversity Medical Center Ljubljana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

adult patients, needing hemodialysis

Exclusion Criteria

acute illness, acute bleeding, known malignancy, current infection, immunosuppressive or anticoagulant therapy, known intolerance to citrate anticoagulation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath